No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Richard Keefe, Ph.D., Director of the Schizophrenia Research Group at the Duke Institute for Brain Sciences, schizophrenia expert
Richard Keefe, Ph.D.
June 28, 2012
Brain & Behavior Research Foundation Scientific Council Member Richard Keefe, Ph.D., Director of the Schizophrenia Research Group at the Duke Institute for...
Ronald S. Duman, Ph.D., Professor Psychiatry and Professor of Neurobiology and of Pharmacology Yale School of Medicine
Ronald S. Duman, Ph.D.
June 27, 2012
Ronald S. Duman, Ph.D., a professor of psychiatry at the Yale School of Medicine, is the principal author of a new study that has found that the gene neuritin...
Helen Mayberg, M.D., professor of Psychiatry and Neurology at Emory University
Helen Mayberg, M.D.
June 21, 2012
Scientific Council Members Eric R. Kandel, M.D., and Helen Mayberg, M.D., discuss how new technologies are moving the field of brain and behavior research...
Scientific Council member Anil K. Malhotra, M.D.,  professor of psychiatry at Hofstra North Shore-LIJ School of Medicine and also serves in the Division of Psychiatry Research in the Zucker Hillside Hospital campus of The Feinstein Institute for Medical Research, both in New York, Expert on mental illness
Anil K. Malhotra, M.D.
June 19, 2012
‘Second’ generation antipsychotic medications are known as atypical antipsychotic drugs (AAPD). Among them are clozapine and olanzapine (Clozaril® and Zyprexa...
June 14, 2012
FOR IMMEDIATE RELEASE  Brain & Behavior Research Foundation Scientific Council Member Karl Deisseroth, M.D., Ph.D., Elected to National Academy of Sciences...

Pages

Subscribe to